Source: Investing.com ↗

Camp4 Therapeutics at Cantor conference: pushing first SYNGAP1 trial

|

Translation unavailable. Please try again.

Original report

Read the original report on Investing.com ↗

Recommended markets

No specific asset was identified in this report; browse live USDT reference pairs.

Browse markets →

USDC/USDT

$1.00

-0.02%

BTC/USDT

$85,666.00

-0.30%

ETH/USDT

$2,727.11

-0.55%

ZEC/USDT

$1,610.79

+7.25%

XRP/USDT

$1.58

+3.71%